The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Regulatory News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.40
Bid: 1.30
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.20 (15.385%)
Open: 1.40
High: 1.40
Low: 1.40
Prev. Close: 1.40
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

13 Jun 2012 10:25

RNS Number : 2670F
Flying Brands Limited
13 June 2012
 



13 June 2012

 

FLYING BRANDS LIMITED

 

RESULT OF ANNUAL GENERAL MEETING

 

The Board of Flying Brands Limited (the "Company") is pleased to announce that at the Company's Annual General Meeting held on Wednesday 13 June 2012 (the "AGM") the resolutions as set out in the Notice of AGM were duly passed on a show of hands.

 

The following levels of proxy appointments were received by the Company prior to the AGM:

 

Resolution

For

Against

Chairman's discretion (Note i)

Votes withheld

Number of shares

% of total

Number of shares

% of total

Number of shares

% of total

To receive and adopt the report and accounts

 

8,306,747

52.25

21,846

0.14

7,568,575

47.61

1,110,300

To approve the Remuneration Committee Report

 

9,345,865

55.05

62,652

0.37

7,569,070

44.58

29,881

To re-appoint John Henwood as a director

 

9,376,637

55.15

56,235

0.33

7,570,059

44.52

4,537

To re-appoint Paul Davidson as a director

 

9,376,521

55.15

55,951

0.33

7,570,059

44.52

4,937

To appoint Stuart Dootson as a director

 

9,408,751

55.34

24,121

0.14

7,570,059

44.52

4,537

To re-appoint Deloitte LLP as auditor and to authorise the directors to determine their remuneration

 

6,256,572

36.8

8,645

0.05

10,738,785

63.15

3,196

Special Resolution - To authorise the directors to make market purchases of ordinary shares

 

6,225,475

36.61

41,155

0.24

10,738,785

63.15

1,783

Special Resolution - To authorise the directors to allot ordinary shares without rights of pre-emption

4,153,661

24.43

2,112,606

12.42

10,738,785

63.15

2,146

 

Notes:

(i) Proxy appointments which gave discretion to the Chairman have been cast in favour of each resolution.

 

(ii) Issued share capital at 13 June 2012: 28,073,735 ordinary shares. Proxy appointments were received from shareholders holding the number of shares shown below, in each case representing the percentage of the issued share capital shown alongside:

 

Resolution 1

15,897,168 shares

56.63%

Resolution 2

16,977,587 shares

60.47%

Resolution 3

17,002,931 shares

60.56%

Resolution 4

17,002,531 shares

60.56%

Resolution 5

17,002,931 shares

60.56%

Resolution 6

17,004,272 shares

60.57%

Resolution 7

17,005,685 shares

60.57%

Resolution 8

17,005,322 shares

60.57%

 

 

(iii) A "Vote Withheld" is not counted towards the votes cast "For" or "Against" the resolutions.

 

For further information, please contact:

 

Flying Brands Limited 01245 228 300

Stephen Cook, Chief Executive

Stuart Dootson, Group Finance Director

 

Smithfield Consultants 020 7360 4900

John Kiely

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGFJMLTMBTBMJT
Date   Source Headline
6th Nov 20204:35 pmRNSPrice Monitoring Extension
6th Nov 20202:05 pmRNSSecond Price Monitoring Extn
6th Nov 20202:00 pmRNSPrice Monitoring Extension
6th Nov 202011:05 amRNSSecond Price Monitoring Extn
6th Nov 202011:00 amRNSPrice Monitoring Extension
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Nov 20209:00 amRNSPrice Monitoring Extension
5th Nov 20207:00 amRNSMontgomery Cancer Center Purchases IB's Software
4th Nov 20207:00 amRNSLSN Software Receives FDA Clearance
30th Oct 202011:05 amRNSSecond Price Monitoring Extn
30th Oct 202011:00 amRNSPrice Monitoring Extension
30th Oct 20207:00 amRNS"Gad Free" Imaging moves to Validation Testing
15th Oct 20207:00 amRNSIB Stroke
8th Oct 20203:41 pmRNSStoneChecker Update
24th Sep 202010:43 amRNSThe Benefits and Significance of IB Neuro
16th Sep 20207:00 amRNSKeck Medical Centre of USC Purchases IB's Software
10th Sep 20207:00 amRNSIB Trax™
4th Sep 20209:03 amRNS“Gad Free” Imaging - One Step Closer
7th Aug 20207:00 amRNSHalf-year Report
5th Aug 20204:41 pmRNSSecond Price Monitoring Extn
5th Aug 20204:35 pmRNSPrice Monitoring Extension
5th Aug 202011:05 amRNSSecond Price Monitoring Extn
5th Aug 202011:00 amRNSPrice Monitoring Extension
5th Aug 20209:53 amRNSStonechecker Update
27th Jul 20207:00 amRNSUpdate - IB Stroke
10th Jul 20207:00 amRNSNew Development Aims to Detect Tumor Infiltration
19th Jun 20207:00 amRNSIB, the Recognised National Standard in MRI DSC
15th Jun 202011:52 amRNSResult of AGM
1st Jun 20207:00 amRNSIB Awarded $2.57m grant
19th May 20209:19 amRNSNotice of AGM
4th May 202010:04 amRNSFinal Results
30th Apr 20201:08 pmRNSDelay in Publishing Final Year Accounts
18th Mar 20202:34 pmRNSIB's Software featured in award-winning article
3rd Mar 20204:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20204:35 pmRNSPrice Monitoring Extension
28th Feb 20201:42 pmRNSTotal Voting Rights
5th Feb 20204:30 pmRNSConversion of Loan Notes - Correction
5th Feb 20203:20 pmRNSConversion of Loan Notes
27th Jan 20209:29 amRNSImaging Biometrics Adds to Development Team
20th Jan 20207:00 amRNSKFDA Clearance for StoneChecker Software
13th Jan 202011:35 amRNSExercise of Options
9th Jan 20207:00 amRNSImaging Biometrics Partners with AI Metrics
18th Dec 201912:46 pmRNSBoard Changes and Restructuring Initiatives
7th Nov 20197:01 amRNSInitiation of IB Stroke Project
2nd Oct 20192:00 pmRNSPrice Monitoring Extension
1st Oct 20192:05 pmRNSSecond Price Monitoring Extn
1st Oct 20192:00 pmRNSPrice Monitoring Extension
1st Oct 201911:05 amRNSSecond Price Monitoring Extn
1st Oct 201911:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.